Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

Summary

The goal of this clinical trial is to find if levels of a protein called AXL in tumor cells relate to how tumors respond to cetuximab (CTX) combined with imatinib in participants with head and neck cancer. This interventional study will occur in the time between diagnosis of your cancer and surgery to remove your tumor or radiation or chemoradiation treatment of your primary cancer. Participants will undergo a research blood draw and a research biopsy as part of the screening process, and will be in this research study for approximately 13 to 16 months.

Timeline

Start

2023-04-18

Primary completion

2026-10-31

Completion

2026-10-31

Drugs

Indications